|
A system service check of the medrad® stellant flex injection system (serial number (b)(6)) was completed on (b)(6) 2026.During that visit, the bayer field service engineer performed pressure calibration and verified that the injector system was operating within specification.The medrad® stellant flex disposable set used during the procedure was discarded by the site and was therefore unavailable for evaluation.The customer was unable to provide the disposable lot number associated with the reported event; consequently, testing of retained samples was not possible.The customer accepted an offer of additional clinical applications training, which is scheduled for (b)(6) 2026.The site continues to use the medrad® stellant flex injection system following the reported event, with no further issues reported.A review of the device history record (dhr) confirmed that the system was manufactured in accordance with established requirements, with no identified deviations, nonconformances, failures, or quality related issues.The medrad® stellant flex injection system operator's manual includes the following precautions: vessel hazard - serious patient injury may result.Follow institutional extravasation minimization techniques.A small volume test injection may be used to confirm venous access.It is recommended that the operator remain at the patient's side at the beginning of the injection and instruct the patient to immediately report any pain or change in sensation during injection.Check for extravasation of contrast or saline during injection.If extravasation is detected, stop the injection and follow the facility's policy regarding treatment.This information does not constitute an admission that the device, the company, or its employees caused or contributed to a reportable event.
|
|
Bayer medical care was notified on april 7, 2026, of an event that occurred on (b)(6) 2026, involving a 47-year-old male patient who underwent a ct examination of the abdomen and pelvis using a medrad® stellant flex injection system (serial number (b)(6)).A 20 gauge intravenous catheter was placed in the patient's left antecubital vein.During contrast injection, the patient reported pain, and approximately 50 ml of contrast was reported to have extravasated into the left upper arm.Post event care included elevation of the affected limb and application of cold compresses.The patient later presented to an urgent care facility on the same evening, reporting numbness in the hands and fingers with increasing pain.During follow up the next day, the patient reported that symptoms had been resolved.
|